A large pharmaceutical company's pharmaceutical intermediate cooperation project

Customer Introduction:

Customer Name: A large pharmaceutical manufacturing enterprise

Industry: Pharmaceutical and chemical industry

Enterprise Scale/Background: One of the top 100 pharmaceutical companies in China, with products covering multiple treatment fields such as anti infective drugs, anti-tumor drugs, cardiovascular and cerebrovascular drugs, etc.

Project Background/Customer Pain Points:

Pain Point 1: With the advancement of new drug development and consistency evaluation of generic drugs, customers' requirements for pharmaceutical intermediates in terms of purity, chirality control, and inter batch stability are increasing, and traditional suppliers can no longer meet their quality standards and process matching needs.

Pain point 2: The key intermediates for multiple API projects of the customer are imported and purchased from abroad, which has a long procurement cycle, high costs, and the risk of supply chain interruption. Therefore, localization substitution certification is needed to reduce procurement costs and stabilize supply.

Pain point 3: The customer is looking for a partner who has GMP compliance awareness and can provide long-term stable supply. At the same time, the supplier is required to have process confidentiality and intellectual property protection capabilities.

Solution:

Core products/services used: Pharmaceutical pesticide intermediate series products

Solution Overview: The company leverages its technological advantages in organic synthesis and trace impurity control to provide customers with full process services for key pharmaceutical intermediates from sample development, small-scale testing, pilot testing to large-scale production, and cooperates to complete supplier certification and auditing.

Implementation key steps:

Based on the quality standards and process requirements provided by the customer, complete sample development and send for inspection confirmation.

Cooperate with customers to conduct on-site audits of suppliers, submit complete quality system documents and process information. After successfully passing the audit,

enters the small batch supply verification stage, tracking the performance of each batch of products in the customer's downstream processes and making necessary adjustments and optimizations. Gradually expand the supply scale and establish long-term strategic partnerships.

Implementation cycle: about 4-6 months

Implementation effect (data-driven):

Effect 1: The purity of key intermediates reaches 99.8% or above, and the content of single impurities is controlled below 0.1% [Data source: Customer quality department testing report]

Effect 2: The supply cost is reduced by about 25-30% compared to imported procurement [Data source: Customer procurement department calculation]

Effect 3: The delivery cycle is shortened from 4-6 weeks required for imports to less than 1 week, significantly reducing customers' safety stock requirements [Data source: Customer] Feedback:

Effect 4: For 12 consecutive months, the supply qualification has reached 99%, and the customer has evaluated it as an excellent supplier of the year and given recognition. [Data source: Customer supplier evaluation]

Customer testimony:

“ Jiayuan Biotechnology has demonstrated strong professionalism in the quality control and production process of pharmaceutical intermediates, with high batch stability and timely delivery. It has been rated as our excellent supplier for three consecutive years. I hope to deepen cooperation on more projects. ”

- Supply Chain Director